DHA Nursing Exam study materials
DHA Nursing Exam study resources

DHA Nursing Exam: Pharmacology and Medication Safety

DHA Nursing Exam · Work through your exam, one topic at a time.

All guide sections

Pharmacology and Medication Safety

What to master

Anchor on the rights of administration (right patient, drug, dose, route, time, documentation, reason, response), two independent identifiers, and the concept of high-alert medications requiring independent double checks: insulin, heparin, opioids, chemotherapy, concentrated electrolytes, and neuromuscular blockers.

Know pharmacokinetics (absorption, distribution, metabolism, excretion) and how it shifts with age, liver and kidney function. Know the major interaction and antidote pairs: opioid → naloxone; benzodiazepine → flumazenil; heparin → protamine sulfate; warfarin → vitamin K (and fresh frozen plasma for major bleeding); paracetamol/acetaminophen overdose → N-acetylcysteine; digoxin → digoxin immune Fab; magnesium → calcium gluconate.

Know monitoring parameters: INR for warfarin, aPTT/anti-Xa for heparin, blood glucose and potassium with insulin, therapeutic drug levels for digoxin and vancomycin.

Traps in questions

  • Look-alike/sound-alike names and trailing-zero or unit errors (mg vs mcg, units never abbreviated as "U").
  • Questions where the ordered dose is wrong - you must calculate and question rather than administer.
  • Confusing adverse effect with allergic reaction; a true allergy goes in the chart and the drug is withheld.
  • Assuming a patient may take an oral medication while NPO or vomiting.

Worked example

Order: heparin infusion for a patient whose aPTT is 110 seconds (therapeutic range roughly 60–80) and who has new gum bleeding and haematuria. Options: continue the infusion, increase the rate, stop the infusion and notify the provider, give vitamin K. Choose stop the infusion and notify - this is over-anticoagulation with bleeding; protamine is the antidote if reversal is ordered.

Rule of thumb

Two identifiers, one calculation check, and an independent double check for every high-alert drug.